X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (313) 313
malaria (282) 282
index medicus (240) 240
parasitic diseases (192) 192
female (183) 183
infectious diseases (174) 174
male (164) 164
child (150) 150
mali (148) 148
child, preschool (147) 147
tropical medicine (126) 126
animals (121) 121
plasmodium falciparum (121) 121
research (120) 120
children (118) 118
infant (108) 108
parasitology (108) 108
adult (103) 103
adolescent (99) 99
immunology (94) 94
mali - epidemiology (88) 88
parasites (88) 88
infections (70) 70
health aspects (69) 69
life sciences (65) 65
malaria, falciparum - epidemiology (64) 64
medicine (64) 64
vector-borne diseases (63) 63
research article (61) 61
plasmodium falciparum - immunology (59) 59
public, environmental & occupational health (58) 58
epidemiology (57) 57
infection (56) 56
antimalarials - therapeutic use (55) 55
young adult (55) 55
multidisciplinary sciences (54) 54
studies (54) 54
vaccines (54) 54
antigens (52) 52
article (52) 52
plasmodium-falciparum (52) 52
malaria, falciparum - immunology (51) 51
malaria, falciparum - parasitology (49) 49
plasmodium falciparum - genetics (48) 48
risk factors (47) 47
drug combinations (46) 46
medical research (46) 46
microbiology (46) 46
efficacy (45) 45
middle aged (45) 45
plasmodium-falciparum malaria (45) 45
africa (44) 44
infectious and parasitic diseases (44) 44
malaria, falciparum - prevention & control (44) 44
seasons (43) 43
abridged index medicus (42) 42
erythrocytes (42) 42
prevalence (42) 42
genetic aspects (41) 41
science (41) 41
malaria, falciparum - drug therapy (40) 40
analysis (39) 39
prevention (39) 39
malaria - epidemiology (38) 38
arctic medicine. tropical medicine (37) 37
pregnancy (36) 36
public health (36) 36
blood (35) 35
protection (35) 35
tropical diseases (35) 35
antibodies (34) 34
antigens, protozoan - immunology (34) 34
clinical trials (34) 34
malaria vaccine (34) 34
polymerase chain reaction (34) 34
proteins (34) 34
disease transmission (33) 33
drug resistance (33) 33
malaria vaccines - immunology (32) 32
malaria - prevention & control (31) 31
training (31) 31
transmission (31) 31
antibodies, protozoan - blood (30) 30
human health and pathology (30) 30
plasmodium falciparum - drug effects (30) 30
drug therapy (29) 29
genotype (29) 29
immunity (29) 29
treatment outcome (29) 29
population (28) 28
pyrimethamine (28) 28
anemia (27) 27
antimalarials (27) 27
care and treatment (27) 27
cerebral malaria (27) 27
mortality (27) 27
resistance (27) 27
plasmodium falciparum - isolation & purification (26) 26
protozoan proteins - immunology (26) 26
alleles (25) 25
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS Medicine, ISSN 1549-1277, 2011, Volume 8, Issue 1, p. e1000406
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10016, pp. 318 - 319
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S0140-6736(15)00807-7 Byline: Brian Greenwood, Ogobara K Doumbo Author... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | Models, Theoretical | Malaria Vaccines - economics | Malaria, Falciparum - prevention & control | Public Health | Humans | Malaria | Vaccines | Immunization | Mortality
Journal Article
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 5, pp. 498 - 509
Summary Background Plasmodium falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria sporozoite vaccine that has been... 
Infectious Disease | IMMUNIZATION | IMMUNITY | INFECTIOUS DISEASES | PROTECTION | MEMORY | NONREPLICATING SPOROZOITE VACCINE | GAMBIA | MEN | HUMANS | Malaria, Falciparum - prevention & control | Double-Blind Method | Humans | Fluorenes - therapeutic use | Artemisinins - administration & dosage | Male | Antimalarials - therapeutic use | Plasmodium falciparum - immunology | Ethanolamines - administration & dosage | Artemisinins - therapeutic use | Vaccination - methods | Antimalarials - administration & dosage | Mali | Adolescent | Adult | Ethanolamines - therapeutic use | Female | Fluorenes - administration & dosage | Immunization Schedule | Plasmodium falciparum | Medical research | Malaria | Parasitic diseases | Clinical trials | Medicine, Experimental | Product development | Adults | Vaccines | Analysis | Vaccination | Biometrics | Asymptotic properties | Toxicity | Antibodies | Bites | Homology | Infections | Parasites | Developing countries--LDCs | Antibody response | Incidence | Hepatitis | Towns | Alignment | Cryopreservation | Syphilis | Human immunodeficiency virus--HIV | Attenuation | Libraries | Masking | Safety | Drug dosages | Age | Circumsporozoite protein | EKG | Antigens | Hum | Immunological memory | Effectiveness | Review boards | Abnormalities | Hypersensitivity | BCG | Contraception | Exposure | Vectors | Appendix | Pregnancy | Disease transmission | Infectious diseases | Immunogenicity | Artemether | Added value | Differentiation
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2017, Volume 12, Issue 9, p. e0184621
Journal Article
Vaccine, ISSN 0264-410X, 2015, Volume 33, Issue 52, pp. 7452 - 7461
Journal Article
Nature Immunology, ISSN 1529-2908, 02/2012, Volume 13, Issue 2, pp. 188 - 195
Infection of erythrocytes with Plasmodium species induces clinical malaria. Parasite-specific CD4(+) T cells correlate with lower parasite burdens and severity... 
B-CELLS | CD4 T-CELLS | FALCIPARUM-MALARIA | PATHWAY | IMMUNE-RESPONSES | PERSISTENCE | VACCINATION | IMMUNOLOGY | EXPRESSION | EXHAUSTION | EXPOSURE | Prevention | Plasmodium falciparum | Malaria | Erythrocytes | Causes of | Development and progression | Research | T cells | Health aspects
Journal Article